![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » MERLION PHARMACEUTICALS PTE LTD ANNOUNCES THE COMPLETION OF MERGER WITH COMBINATURE BIOPHARM AG AND ATHELAS SA
MERLION PHARMACEUTICALS PTE LTD ANNOUNCES THE COMPLETION OF MERGER WITH COMBINATURE BIOPHARM AG AND ATHELAS SA
MerLion Pharmaceuticals Pte Ltd (MerLion) of Singapore, the world's leading natural products-based drug discovery company, announces that it has completed a merger by exchange of shares with Combinature Biopharm AG (Berlin, Germany) and Athelas SA (Geneva, Switzerland). Both European companies become 100% subsidiaries of MerLion, whose headquarters and drug discovery research centre is based in Singapore. Drug development of its anti-infective programmes and nuclear magnetic resonance screening activities will be conducted from Berlin. BioSpace (http://www.biospace.com/news_story.aspx?StoryID=27963&full=1)
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
21Oct